It is possible that these cells may be best preserved by early intervention with ART, including CCR5 blocking antiretroviral therapy, such as Maraviroc, commenced during primary HIV-1 infection, although a lack of reconstitution may necessitate intervention, for example with exogenous IL-7, or revaccination. The gene discussed is IL7; the disease is HIV-1 infection.